Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
2,123.00
+46.00 (2.21%)
At close: Dec 23, 2025

Genmab Revenue

Genmab had revenue of $1.02B USD in the quarter ending September 30, 2025, with 25.25% growth. This brings the company's revenue in the last twelve months to $3.47B, up 16.96% year-over-year. In the year 2024, Genmab had annual revenue of $3.00B with 23.13% growth.

Revenue (ttm)
$3.47B
Revenue Growth
+16.96%
P/S Ratio
5.34
Revenue / Employee
$1.29M
Employees
2,682
Market Cap
130.78B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.00B564.17M23.13%
Dec 31, 20232.44B351.45M16.83%
Dec 31, 20222.09B800.56M62.19%
Dec 31, 20211.29B-372.56M-22.45%
Dec 31, 20201.66B854.43M106.10%
Dec 31, 2019805.32M340.75M73.35%
Dec 31, 2018464.57M83.37M21.87%
Dec 31, 2017381.20M-144.81M-27.53%
Dec 31, 2016526.01M195.32M59.07%
Dec 31, 2015330.68M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk315.60B
Coloplast27.87B
H. Lundbeck24.08B
Demant22.59B
GN Store Nord17.12B
Zealand Pharma9.16B
Bavarian Nordic6.89B
ALK-Abelló6.08B
Revenue Rankings